Sunshine Biopharma Inc. (SBFM)
| Bid | 1.4 |
| Market Cap | 6.42M |
| Revenue (ttm) | 34.87M |
| Net Income (ttm) | -5.13M |
| EPS (ttm) | -5.76 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 1.45 |
| Volume | 22,988 |
| Avg. Volume (20D) | 1,434,057 |
| Open | 1.43 |
| Previous Close | 1.43 |
| Day's Range | 1.38 - 1.42 |
| 52-Week Range | 1.17 - 12.80 |
| Beta | 1.18 |
About SBFM
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for SBFM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 month ago · accessnewswire.com
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct OfferingFORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of t...
2 months ago · accessnewswire.com
Sunshine Biopharma Announces Positive Results of mRNA Therapy for CancerFORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a...
2 months ago · accessnewswire.com
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last YearFORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of t...
